PMID: 6166712May 1, 1981Paper

Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition

The Journal of Experimental Medicine
J W KapplerP Marrack

Abstract

We developed a method for production of antigen-specific, H-2-restricted T cell hybrids. The tumor cell partner in the fusions was itself a T cell hybrid, FS6-14.13.AG2 (or its derivatives), which could be induced to produce the growth factor, interleukin-2 (IL-2), in response to a challenge with concanavalin A, but had no known antigen specificity. The normal T cell partner in the fusions was a population of lymph node T cell blasts that had been highly enriched in antigen-specific, H-2-restricted T cells by in vivo immunization, followed by in vitro challenge with antigen and clonal expansion in IL-2-containing medium. These fusions produced hybrids that grew constitutively in culture. A sizable proportion of the hybrids demonstrated the ability to produce IL-2 in response to a challenge with specific antigen presented by irradiated spleen cells of the appropriate H-2 type. Four cloned antigen/H-2-specific hybrid lines were produced. AO-40.10 responded to chicken ovalbumin (OVA) when presented by I-A(k)-bearing cells. DC1.18.3 responded to the apo form of beef cytochrome c when presented with I-A(d). AODK-10.4 responded to keyhole limpet hemocyanin (KLH) presented with I-A (d). AODK-1.16 also responded to KLH presented by a p...Continue Reading

References

Jan 1, 1976·Scandinavian Journal of Immunology·C A JanewayH Binz
Aug 1, 1979·European Journal of Immunology·H von BoehmerW Haas
Dec 1, 1979·The Journal of Experimental Medicine·J Watson
Oct 1, 1978·The Journal of Experimental Medicine·P P JonesH O McDevitt
May 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·M J Bevan
Mar 1, 1978·The Journal of Experimental Medicine·R M ZinkernagelJ Klein
Aug 3, 1978·Nature·S KontiainenM Feldmann
Mar 25, 1977·Science·W E Paul, B Benacerraf
Nov 1, 1975·The Journal of Experimental Medicine·R D GordonL E Samelson
Dec 22, 1970·Biochimica Et Biophysica Acta·G Corradin, H A Harbury
Sep 1, 1967·The Journal of Experimental Medicine·R I Mishell, R W Dutton
Oct 1, 1980·The Journal of Experimental Medicine·D H KatzA Altman
Apr 1, 1980·The Journal of Experimental Medicine·A L Glasebrook, F W Fitch
May 1, 1980·The Journal of Experimental Medicine·T Hünig, M J Bevan
Oct 1, 1980·The Journal of Experimental Medicine·L HarwellJ Kappler
Oct 1, 1975·European Journal of Immunology·K Eichmann, K Rajewsky
Jan 1, 1971·European Journal of Immunology·N K Jerne

❮ Previous
Next ❯

Citations

Jan 1, 1996·Journal of Cellular Physiology·S BarreraJ K Roche
Apr 1, 1998·Protein Science : a Publication of the Protein Society·C A ScottL Teyton
Jan 1, 1982·Immunogenetics·M SuzanB Rubin
Jan 1, 1986·Immunogenetics·S L EpsteinD H Sachs
Jan 1, 1986·Immunogenetics·R G PalfreeU Hammerling
Jul 1, 1989·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·C Y LinP P Lee
Jan 1, 1996·Immunogenetics·A LennonC Alcaïde-Loridan
Nov 1, 1996·Archives of Dermatological Research·H JonuleitJ Knop
Jan 1, 1994·International Journal of Clinical & Laboratory Research·M T ScupoliR S Accolla
Dec 1, 1981·In Vitro·N R KlinmanL A Sherman
Jan 1, 1986·Immunologic Research·M B ZaleskiJ S Reichner
Jan 1, 1989·Immunologic Research·D L Hamilos
Jan 1, 1990·Immunologic Research·S KomoriM I Greene
Aug 13, 1982·Journal of Immunological Methods·B B Beezley, N H Ruddle
Jan 1, 1982·Journal of Immunological Methods·B Sredni
May 27, 1983·Journal of Immunological Methods·S L Holbeck, G T Nepom
Aug 3, 1984·Journal of Immunological Methods·B E Elliott, R G Palfree
Dec 17, 1985·Journal of Immunological Methods·R L Fairchild, J W Moorhead
Nov 28, 1985·Journal of Immunological Methods·T M Aune
May 8, 1990·Journal of Immunological Methods·P PortolésC A Janeway
Sep 13, 1991·Journal of Immunological Methods·N W RoehmA L Glasebrook
Jun 3, 1991·Journal of Immunological Methods·S Gillard-BlaasJ Langhorne

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.